Nowadays, researches on new medicines and treatments are essential for improving health and dealing with diseases. Who do you think should fund these researches: private companies or governments?
A.I. Score
Each colour is one skill. Tap a colour to hide it. Tap it again to show it.
Advances in medicines and clinical treatments underpin longer life expectancy and stronger resilience against emerging diseases. The central question is whether such medical research should be funded mainly by private companies or by governments. I argue that governments should be the primary funders of medicines and treatments, because public financing aligns research priorities with population health and secures equitable access to new treatments.
Firstly, government funding protects medical research agendas from narrow commercial incentives. Public agencies can invest in preventive care, rare diseases and long-term trials on treatments that offer limited short-term profit yet deliver substantial social benefit. For example, vaccination programmes and antimicrobial research require sustained government funding and transparent oversight, which reduce avoidable illness and diet-related diseases at scale.
Admittedly, private companies contribute efficiency, capital and technical expertise to developing medicines, so their role should not be dismissed. However, profit-driven companies can skew innovation towards lucrative chronic treatments and high prices, which restricts public access to essential medicines. When governments set the funding base and regulation, partnerships with private companies can still accelerate the development of medicines while safeguarding affordability. Furthermore, because individuals now have more information about health than in the past yet still suffer from fitness and diet-related diseases, public research into prevention and healthier living is essential for the whole society. Consequently, government funding of this preventive research can promote increased longevity and a better quality of life for citizens.
In conclusion, while private investment in medicines remains valuable, governments should lead the funding of research into new treatments and diseases. Public financing better matches health needs, supports neglected medical fields, and secures fair access to treatments for the wider public.
- Fully addresses the prompt in depth, showing full command of the argument by reformulating the issue in the writer's own words and expanding important points with specificity.
- The argument is supported convincingly with subsidiary points and relevant examples throughout the response.
- Has an effective logical structure, flows smoothly, and can be followed with ease.
- The argument is clear and cohesive and developed systematically at length; a well-developed introduction and conclusion are present, and ideas are organised cohesively into clear, logically sequenced paragraphs.
- Uses a variety of connective devices effectively and consistently to convey relationships between ideas.
- A variety of expressions and vocabulary are used appropriately to formulate ideas with ease and precision throughout the response.
- No signs of limitations restricting what can be communicated.
- Errors in language use, if present, are rare and minor, and meaning is completely clear.
- Shows consistent grammatical control of complex language. Errors are rare and difficult to spot.
- Good command of a broad lexical repertoire, idiomatic expressions and collocations.
- Correct spelling.
- Length is within the required 200 to 300 words.